Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones Cecilia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goff Brian
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gheuens Sarah
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOUSE JACQUALYN A
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CAPELLO JEFFREY D
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scadden David
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schenkein David P
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Owen Catherine E.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Foster-Cheek Kaye I
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Foster-Cheek Kaye I
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOUSE JACQUALYN A
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schenkein David P
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Cynthia
Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scadden David
No Data
No Data